![]() |
|
|
Vol. 9, Issue 1, 15-28, January 1998
-Monophosphate Dehydrogenase Is a Rate-determining
Factor for p53-dependent Growth Regulation
The Molecular Oncology Group, Division of Medical Science, Fox
Chase Cancer Center, Philadelphia, Pennsylvania 19111
We have proposed that reduced activity of inosine-5
-monophosphate
dehydrogenase (IMPD; IMP:NAD oxidoreductase, EC 1.2.1.14), the
rate-limiting enzyme for guanine nucleotide biosynthesis, in response
to wild-type p53 expression, is essential for p53-dependent growth
suppression. A gene transfer strategy was used to demonstrate that
under physiological conditions constitutive IMPD expression prevents
p53-dependent growth suppression. In these studies, expression of
bax and waf1, genes implicated in
p53-dependent growth suppression in response to DNA damage, remains
elevated in response to p53. These findings indicate that under
physiological conditions IMPD is a rate-determining factor for
p53-dependent growth regulation. In addition, they suggest that the
impd gene may be epistatic to bax and
waf1 in growth suppression. Because of the role of IMPD
in the production and balance of GTP and ATP, essential nucleotides for
signal transduction, these results suggest that p53 controls cell
division signals by regulating purine ribonucleotide metabolism.
This article has been cited by other articles:
![]() |
J. M. Hamilton, M. W. Harding, T. Genna, and D. K. Bol A Phase I Dose-Ranging Study of the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of AVN944, an IMPDH Inhibitor, in Healthy Male Volunteers J. Clin. Pharmacol., January 1, 2009; 49(1): 30 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rambhatla, S. Ram-Mohan, J. J. Cheng, and J. L. Sherley Immortal DNA Strand Cosegregation Requires p53/IMPDH-Dependent Asymmetric Self-renewal Associated with Adult Stem Cells Cancer Res., April 15, 2005; 65(8): 3155 - 3161. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Damaraju, F. Visser, J. Zhang, D. Mowles, A. M. L. Ng, J. D. Young, H. N. Jayaram, and C. E. Cass Role of Human Nucleoside Transporters in the Cellular Uptake of Two Inhibitors of IMP Dehydrogenase, Tiazofurin and Benzamide Riboside Mol. Pharmacol., January 1, 2005; 67(1): 273 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Escobar-Henriques, M. A. Collart, and B. Daignan-Fornier Transcription Initiation of the Yeast IMD2 Gene Is Abolished in Response to Nutrient Limitation through a Sequence in Its Coding Region Mol. Cell. Biol., September 1, 2003; 23(17): 6279 - 6290. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Merok, J. A. Lansita, J. R. Tunstead, and J. L. Sherley Cosegregation of Chromosomes Containing Immortal DNA Strands in Cells That Cycle with Asymmetric Stem Cell Kinetics Cancer Res., December 1, 2002; 62(23): 6791 - 6795. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Sherley Asymmetric Cell Kinetics Genes: The Key to Expansion of Adult Stem Cells in Culture Stem Cells, November 1, 2002; 20(6): 561 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Batiuk, C. Schnizlein-Bick, Z. Plotkin, and P. C. Dagher Guanine nucleosides and Jurkat cell death: roles of ATP depletion and accumulation of deoxyribonucleotides Am J Physiol Cell Physiol, December 1, 2001; 281(6): C1776 - C1784. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. SAMPOL, B. DUSSOL, E. FENOUILLET, C. CAPO, J.-L. MEGE, G. HALIMI, G. BECHIS, P. BRUNET, H. ROCHAT, Y. BERLAND, et al. High Adenosine and Deoxyadenosine Concentrations in Mononuclear Cells of Hemodialyzed Patients J. Am. Soc. Nephrol., August 1, 2001; 12(8): 1721 - 1728. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. DONAHUE, M. RAZMARA, J. B. HOEK, and T. B. KNUDSEN Direct influence of the p53 tumor suppressor on mitochondrial biogenesis and function FASEB J, March 1, 2001; 15(3): 635 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Metz, S. Holland, L. Johnson, E. Espling, M. Rabaglia, V. Segu, J. S. Brockenbrough, and P. O. Tran Inosine-5'-Monophosphate Dehydrogenase Is Required for Mitogenic Competence of Transformed Pancreatic {beta} Cells Endocrinology, January 1, 2001; 142(1): 193 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Shaw and D. Reines Saccharomyces cerevisiae Transcription Elongation Mutants Are Defective in PUR5 Induction in Response to Nucleotide Depletion Mol. Cell. Biol., October 15, 2000; 20(20): 7427 - 7437. [Abstract] [Full Text] |
||||
![]() |
P. C. Dagher Modeling ischemia in vitro: selective depletion of adenine and guanine nucleotide pools Am J Physiol Cell Physiol, October 1, 2000; 279(4): C1270 - C1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Li, V. B. G. Segu, M. E. Rabaglia, R.-H. Luo, A. Kowluru, and S. A. Metz Prolonged Depletion of Guanosine Triphosphate Induces Death of Insulin-Secreting Cells by Apoptosis Endocrinology, September 1, 1998; 139(9): 3752 - 3762. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Escobar-Henriques and B. Daignan-Fornier Transcriptional Regulation of the Yeast GMP Synthesis Pathway by Its End Products J. Biol. Chem., January 5, 2001; 276(2): 1523 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Shaw, J. L. Wilson, K. T. Smith, and D. Reines Regulation of an IMP Dehydrogenase Gene and Its Overexpression in Drug-sensitive Transcription Elongation Mutants of Yeast J. Biol. Chem., August 24, 2001; 276(35): 32905 - 32916. [Abstract] [Full Text] [PDF] |
||||